-+ 0.00%
-+ 0.00%
-+ 0.00%

TELOMIR PHARMACEUTICALS INC - TO SUBMIT IND & INAD APPLICATION BY Q4 2025, WITH CLINICAL TRIALS PLANNED FOR 2026

Reuters·12/23/2024 12:03:43

Please log in to view news